SYY
56
12
ESS
36
3
ZION
63
4
MA
71
2
CINF
54
3
FIS
58
-7
VRSN
58
8
O
48
9
GILD
65
2
EL
42
5
ETN
69
-2
CMA
55
2
BBY
42
-8
MMC
67
3
HAS
63
3
KO
63
6
EIX
40
-11
CVX
32
4
TEL
74
13
A
51
4
SYY
56
12
ESS
36
3
ZION
63
4
MA
71
2
CINF
54
3
FIS
58
-7
VRSN
58
8
O
48
9
GILD
65
2
EL
42
5
ETN
69
-2
CMA
55
2
BBY
42
-8
MMC
67
3
HAS
63
3
KO
63
6
EIX
40
-11
CVX
32
4
TEL
74
13
A
51
4
Financhill
Back

Intellia Therapeutics Vs. Pacific Biosciences of California Industry Stock Comparison

Sell
15

NTLA
Intellia Therapeutics

Last Price:
$6.89
Seasonality Move:
17.23%
Sell
43

PACB
Pacific Biosciences of California

Last Price:
$1.02
Seasonality Move:
5.93%
Sell
15
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $7.45. The Score for NTLA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.04. The Score for PACB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $7.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 41.69 Sell
Chaikin Money Flow: 18219669 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.87 - 9.19) Sell
Bollinger Bands (100): (7.75 - 10.75) Sell

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 46.49 Sell
Chaikin Money Flow: -8635330 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1 - 1.14) Sell
Bollinger Bands (100): (1.09 - 1.67) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.12 Sell
20-day SMA: 8.56 Sell
50-day SMA: 8.1 Sell
200-day SMA: 13.61 Sell
8-day EMA: 8.81 Sell
20-day EMA: 8.63 Sell
50-day EMA: 8.66 Sell
200-day EMA: 13.35 Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Buy
20-day SMA: 1.06 Sell
50-day SMA: 1.16 Sell
200-day SMA: 1.6 Sell
8-day EMA: 1.01 Buy
20-day EMA: 1.06 Sell
50-day EMA: 1.17 Sell
200-day EMA: 1.84 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.03 per share, and an increase next year of $0.28 per share.

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.18 per share, and an increase next year of $0.13 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):